Trials / Terminated
TerminatedNCT04976231
MPS II Immunophenotyping
Immunophenotyping of Patients With MPS II Treated With Enzyme Replacement Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate how participant's body's immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.
Conditions
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2024-04-26
- Completion
- 2024-04-26
- First posted
- 2021-07-26
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04976231. Inclusion in this directory is not an endorsement.